1. Home
  2. MAYS vs NAMSW Comparison

MAYS vs NAMSW Comparison

Compare MAYS & NAMSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAYS
  • NAMSW
  • Stock Information
  • Founded
  • MAYS 1924
  • NAMSW N/A
  • Country
  • MAYS United States
  • NAMSW Netherlands
  • Employees
  • MAYS N/A
  • NAMSW 29
  • Industry
  • MAYS Building operators
  • NAMSW Biotechnology: Pharmaceutical Preparations
  • Sector
  • MAYS Real Estate
  • NAMSW Health Care
  • Exchange
  • MAYS Nasdaq
  • NAMSW Nasdaq
  • Market Cap
  • MAYS N/A
  • NAMSW N/A
  • IPO Year
  • MAYS N/A
  • NAMSW N/A
  • Fundamental
  • Price
  • MAYS $43.33
  • NAMSW $9.00
  • Analyst Decision
  • MAYS
  • NAMSW
  • Analyst Count
  • MAYS 0
  • NAMSW 0
  • Target Price
  • MAYS N/A
  • NAMSW N/A
  • AVG Volume (30 Days)
  • MAYS 67.0
  • NAMSW N/A
  • Earning Date
  • MAYS 06-13-2024
  • NAMSW N/A
  • Dividend Yield
  • MAYS N/A
  • NAMSW N/A
  • EPS Growth
  • MAYS N/A
  • NAMSW N/A
  • EPS
  • MAYS N/A
  • NAMSW N/A
  • Revenue
  • MAYS $21,508,474.00
  • NAMSW N/A
  • Revenue This Year
  • MAYS N/A
  • NAMSW N/A
  • Revenue Next Year
  • MAYS N/A
  • NAMSW N/A
  • P/E Ratio
  • MAYS N/A
  • NAMSW N/A
  • Revenue Growth
  • MAYS N/A
  • NAMSW N/A
  • 52 Week Low
  • MAYS $42.01
  • NAMSW N/A
  • 52 Week High
  • MAYS $56.12
  • NAMSW N/A
  • Technical
  • Relative Strength Index (RSI)
  • MAYS 22.66
  • NAMSW 47.49
  • Support Level
  • MAYS $43.80
  • NAMSW $9.40
  • Resistance Level
  • MAYS $47.00
  • NAMSW $10.14
  • Average True Range (ATR)
  • MAYS 0.00
  • NAMSW 0.44
  • MACD
  • MAYS -0.30
  • NAMSW -0.12
  • Stochastic Oscillator
  • MAYS 0.00
  • NAMSW 24.31

About MAYS J. W. Mays Inc.

J. W. Mays Inc is a real estate company. It is engaged in the leasing of real estate and operates a number of commercial real estate properties in New York. The company leases its properties to retail, restaurant, commercial, and other tenants. Its properties are located in Brooklyn, Circleville, Fishkill, Jamaica, Levittown, and Massapequa.

About NAMSW NewAmsterdam Pharma Company N.V. Warrant

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

Share on Social Networks: